Disclosures for "Real-world Use of Deutetrabenazine Reduces Tardive Dyskinesia Severity and Improves Quality of Life: Patient-reported Outcomes in the IMPACT-TD Study"
-
Stacy Finkbeiner has received personal compensation for serving as an employee of Teva Pharmaceuticals.
-
Martijn Konings has received personal compensation for serving as an employee of Teva Pharmaceuticals. Martijn Konings has stock in Teva Pharmaceuticals.
-
Dr. Henegar has stock in Teva.
-
Diana Klakotskaia has received personal compensation for serving as an employee of Teva Pharmaceuticals. Diana Klakotskaia has stock in Teva Pharmaceuticals.
-
Dr. Yu has nothing to disclose.
-
Dr. Jackson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for teva. Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for teva . Dr. Jackson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for teva.